Observational studyFrontiers in immunology2022

Use of Tumor Necrosis Factor-α Antagonists Is Associated With Attenuated IgG Antibody Response Against SARS-CoV-2 in Vaccinated Patients With Inflammatory Bowel Disease.

Antonius T Otten et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.